Concepts (303)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Acetates
- Adenocarcinoma
- Adenosylmethionine Decarboxylase
- Adenoviruses, Human
- Administration, Oral
- Adolescent
- Adrenal Glands
- Adrenalectomy
- Adult
- Aged
- Aged, 80 and over
- Alkyl and Aryl Transferases
- Amidines
- Amino Acid Sequence
- Aminoglycosides
- Analysis of Variance
- Anemia
- Angiogenesis Inhibitors
- Animals
- Anthraquinones
- Anti-Bacterial Agents
- Antibodies
- Antibodies, Monoclonal
- Antibodies, Viral
- Antibody Formation
- Anticoagulants
- Antigens, Neoplasm
- Antimetabolites, Antineoplastic
- Antineoplastic Agents
- Antineoplastic Agents, Alkylating
- Antineoplastic Agents, Hormonal
- Antineoplastic Agents, Phytogenic
- Antineoplastic Combined Chemotherapy Protocols
- Apoptosis
- Area Under Curve
- Asthenia
- ATP-Binding Cassette Transporters
- Base Sequence
- Benzimidazoles
- Benzofurans
- Benzoquinones
- Bibenzyls
- Bilirubin
- Biological Availability
- Biopsy
- Biphenyl Compounds
- Blood Coagulation
- Blood Platelets
- Body Weight
- Bone Marrow
- Brain Edema
- Brain Neoplasms
- Breast Neoplasms
- Butyrates
- Camptothecin
- Carbamates
- Carbazoles
- Carboplatin
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carmustine
- Cell Adhesion Molecules
- Cell Cycle
- Cell Differentiation
- Cell Division
- Cholestanols
- Chromatography, High Pressure Liquid
- Cisplatin
- Clinical Trials as Topic
- Cohort Studies
- Colorectal Neoplasms
- Corticotropin-Releasing Hormone
- Cytomegalovirus
- Cytoprotection
- Cytosine
- Dacarbazine
- Decision Support Techniques
- Deoxycytidine
- Depsipeptides
- Dexamethasone
- Diagnostic Imaging
- Diarrhea
- Dietary Supplements
- Dioxolanes
- Disease Progression
- Disease-Free Survival
- DNA
- Dose-Response Relationship, Drug
- Double-Blind Method
- Down-Regulation
- Drug Administration Schedule
- Drug Combinations
- Drug Design
- Drug Eruptions
- Drug Interactions
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Drug Screening Assays, Antitumor
- Drug Synergism
- Edema
- Electroretinography
- Enzyme Inhibitors
- Enzyme-Linked Immunosorbent Assay
- Etoposide
- Europe
- Evoked Potentials, Visual
- Exanthema
- Farnesyltranstransferase
- Fatigue
- Feasibility Studies
- Female
- Fluorouracil
- Folic Acid
- Follow-Up Studies
- Gastrointestinal Diseases
- Gene Frequency
- Genes, p53
- Genetic Vectors
- Genetics, Population
- Glucosides
- Glutamates
- Granulocyte Colony-Stimulating Factor
- Growth Inhibitors
- Guanine
- Guideline Adherence
- Half-Life
- Haplotypes
- Headache
- Heart Failure
- Hematologic Diseases
- Heparin, Low-Molecular-Weight
- Heterocyclic Compounds, 1-Ring
- HLA-A Antigens
- HLA-B Antigens
- HLA-B27 Antigen
- Hospitalization
- HSP90 Heat-Shock Proteins
- Humans
- Hydrocortisone
- Image Processing, Computer-Assisted
- Immunity, Cellular
- Immunoconjugates
- Immunogenetics
- Immunohistochemistry
- Immunosuppressive Agents
- Indans
- Indoles
- Infusions, Intravenous
- Inhibitory Concentration 50
- Intercalating Agents
- Isotope Labeling
- Isoxazoles
| - Kidney Diseases
- Kidney Failure, Chronic
- Kinetics
- Lactams, Macrocyclic
- Lactates
- Leukemia
- Leukemia, Experimental
- Leukocytes, Mononuclear
- Liver
- Liver Diseases
- Liver Function Tests
- Lung Neoplasms
- Lymphopenia
- Magnetic Resonance Imaging
- Male
- Matrix Metalloproteinase 2
- Matrix Metalloproteinase 9
- Matrix Metalloproteinases
- Maximum Tolerated Dose
- Maytansine
- Medical Audit
- Medical Records
- Melanoma
- Melanoma, Experimental
- Metabolic Clearance Rate
- Metalloendopeptidases
- Mice
- Mice, Nude
- Middle Aged
- Mitogen-Activated Protein Kinases
- Models, Chemical
- Molecular Probe Techniques
- Molecular Sequence Data
- Molecular Structure
- Morpholines
- Mucin-1
- Multidrug Resistance-Associated Proteins
- Mutation
- Nausea
- Neoplasm Metastasis
- Neoplasm Proteins
- Neoplasm Staging
- Neoplasm Transplantation
- Neoplasms
- Neutropenia
- Neutrophils
- O(6)-Methylguanine-DNA Methyltransferase
- Oligonucleotides, Antisense
- Oligopeptides
- Oncogene Proteins v-erbB
- Organic Chemicals
- Orotate Phosphoribosyltransferase
- Ovarian Neoplasms
- Oxonic Acid
- Paclitaxel
- Partial Thromboplastin Time
- Patient Selection
- Peripheral Nervous System Diseases
- Phenylbutyrates
- Phenylurea Compounds
- Phosphorylation
- Phthalazines
- Physiological Phenomena
- Pilot Projects
- Piperidines
- Pleural Effusion
- Polyamines
- Polyethylene Glycols
- Positron-Emission Tomography
- Practice Guidelines as Topic
- Prodrugs
- Promoter Regions, Genetic
- Prostate-Specific Antigen
- Prostatic Neoplasms
- Protein Binding
- Protein Kinase Inhibitors
- Protein Prenylation
- Protein Structure, Tertiary
- Protein-Tyrosine Kinases
- Proto-Oncogene Proteins c-bcl-2
- Pulmonary Embolism
- Pyrazines
- Pyrazoles
- Pyrazolones
- Pyridines
- Pyrimidines
- Pyrroles
- Quinazolines
- Quinolines
- Quinolones
- Radioligand Assay
- Radiopharmaceuticals
- ras Proteins
- Receptor Protein-Tyrosine Kinases
- Receptor, erbB-2
- Receptors, Platelet-Derived Growth Factor
- Receptors, Vascular Endothelial Growth Factor
- Regression Analysis
- Retina
- Retinal Diseases
- Rifabutin
- Risk Assessment
- RNA, Messenger
- Safety
- Salvage Therapy
- Sequence Analysis, DNA
- Sesquiterpenes
- Signal Transduction
- Skin
- Solubility
- Statistics, Nonparametric
- Stereoisomerism
- Sterols
- Stilbenes
- Stomach Neoplasms
- Structure-Activity Relationship
- Sulfonylurea Compounds
- Survival Analysis
- Survival Rate
- Tablets
- Taxoids
- Tegafur
- Tetracyclines
- Thalidomide
- Thionucleotides
- Thrombocytopenia
- Time Factors
- Tissue Distribution
- Tissue Inhibitor of Metalloproteinase-2
- Tomography, Emission-Computed
- Tomography, X-Ray Computed
- Topoisomerase I Inhibitors
- Topoisomerase II Inhibitors
- Topotecan
- Transplantation, Heterologous
- Treatment Outcome
- Tumor Cells, Cultured
- Tumor Necrosis Factor-alpha
- Tumor Suppressor Protein p53
- Tyrosine
- Up-Regulation
- Urea
- Uridine
- Vascular Endothelial Growth Factor A
- Venous Thromboembolism
- Venous Thrombosis
- Visual Fields
- Vitamin B 12
- Vitamins
- Vomiting
- Wales
|
Concepts
(303)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_